Gliclazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gliclazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure

Published:2001-01 Issue:1 Volume:34 Page:49-56
ISSN:0100-879X
Container-title:Brazilian Journal of Medical and Biological Research
language:
Short-container-title:Braz J Med Biol Res

Author:

Chazan A.C.S.¹,Gomes M.B.¹

Affiliation:

1. da Universidade Estadual do Rio de Janeiro, Brasil

Publisher

FapUNIFESP (SciELO)

Subject

Cell Biology,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Immunology,Physiology,Biochemistry,General Neuroscience,Biophysics

Link

http://www.scielo.br/pdf/bjmbr/v34n1/3448m.pdf

Reference28 articles.

1. "Secondary failures" in the treatment of diabetes mellitus with tolbutamide and with phenformin;Krall LP;Diabetes,1962

2. Secondary failure to treatment with oral antidiabetic agents in NIDDM;Groop LC;Diabetes Care,1986

3. Characteristics of NIDDM patients with secondary failure to oral antidiabetic therapy;Groop L;American Journal of Medicine,1989

4. Combined therapy with a sulfonylurea plus evening insulin: Safe, reliable and becoming routine;Riddle MC;Hormone and Metabolic Research,1996

5. Comparison of different insulin regimens in elderly patients with NIDDM;Wolffenbuttel BHR;Diabetes Care,1996

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review;Diabetes Therapy;2024-06-27

2. Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control;Cochrane Database of Systematic Reviews;2016-09-18

3. Controlled Porosity Solubility Modulated Osmotic Pump Tablets of Gliclazide;AAPS PharmSciTech;2014-11-07

4. Insulin therapy in type 2 diabetes: what is the evidence?;Diabetes, Obesity and Metabolism;2009-05

5. Unmet needs among patients with Type 2 diabetes and secondary failure to oral anti-diabetic agents;Journal of Endocrinological Investigation;2008-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3